Primary Site >> Colorectal Cancer

Gene >> INPPL1

Journal: Biochem Pharmacol. 2009 Sep 15;78(6):561-72.
Title: Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
Author: Lincova, Eva|Hampl, Ales|Pernicova, Zuzana|Starsichova, Andrea|Krcmar, Pavel|Machala, Miroslav|Kozubik, Alois|Soucek, Karel
PMID: 19433066
Journal: PLoS One. 2013 Nov 8;8(11):e80207.
Title: Global phosphotyrosine proteomics identifies PKCdelta as a marker of responsiveness to Src inhibition in colorectal cancer.
Author: McKinley, Eliot T|Liu, Huiling|McDonald, W Hayes|Luo, Weifeng|Zhao, Ping|Coffey, Robert J|Hanks, Steven K|Manning, H Charles
PMID: 24260357
Journal: BMC Med Genomics. 2014 Jun 18;7:36.
Title: Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
Author: Shanmugam, Vijayalakshmi|Ramanathan, Ramesh K|Lavender, Nicole A|Sinari, Shripad|Chadha, Manpreet|Liang, Winnie S|Kurdoglu, Ahmet|Izatt, Tyler|Christoforides, Alexis|Benson, Hollie|Phillips, Lori|Baker, Angela|Murray, Christopher|Hostetter, Galen|Von Hoff
PMID: 24943349
Journal: Dis Markers. 2014;2014:218968.
Title: High SHIP2 expression indicates poor survival in colorectal cancer.
Author: Yang, Ju|Fu, Maoying|Ding, Yaoguang|Weng, Yajing|Fan, Weifei|Pu, Xiaolin|Ge, Zhijun|Zhan, Feng|Ni, Huihui|Zhang, Wei|Jin, Feng|Xu, Ning|Li, Jiang|Qiu, Liang|Wang, Jun|Gu, Xuefeng
PMID: 25525286
Journal: Oncotarget. 2016 Nov 8;7(45):73525-73540.
Title: Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
Author: Hoekstra, Elmer|Das, Asha M|Willemsen, Marcella|Swets, Marloes|Kuppen, Peter J K|van der Woude, Christien J|Bruno, Marco J|Shah, Jigisha P|Ten Hagen, Timo L M|Chisholm, John D|Kerr, William G|Peppelenbosch, Maikel P|Fuhler, Gwenny M
PMID: 27716613